91 related articles for article (PubMed ID: 6987306)
1. Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect.
Boraschi D; Meltzer MS
J Immunol; 1980 Mar; 124(3):1050-3. PubMed ID: 6987306
[No Abstract] [Full Text] [Related]
2. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.
Boraschi D; Meltzer MS
J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721
[No Abstract] [Full Text] [Related]
3. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
[TBL] [Abstract][Full Text] [Related]
4. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
[TBL] [Abstract][Full Text] [Related]
5. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
[No Abstract] [Full Text] [Related]
6. Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene.
Ruco LP; Meltzer MS; Rosenstreich DL
J Immunol; 1978 Aug; 121(2):543-8. PubMed ID: 681749
[No Abstract] [Full Text] [Related]
7. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
Meltzer MS; Stevenson MM
J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
[No Abstract] [Full Text] [Related]
8. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets.
Adams DO; Marino PA; Meltzer MS
J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698
[TBL] [Abstract][Full Text] [Related]
9. The ADCC capacity of macrophages from C3H/HeJ and A/J mice can be augmented by BCG.
Koren HS; Meltzer MS; Adams DO
J Immunol; 1981 Mar; 126(3):1013-5. PubMed ID: 7007498
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
Boraschi D; Meltzer MS
Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
[No Abstract] [Full Text] [Related]
11. Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus.
Tagliabue A; Boraschi D; McCoy JL
J Immunol; 1980 May; 124(5):2203-8. PubMed ID: 6245137
[No Abstract] [Full Text] [Related]
12. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.
Hopper KE; Harrison J; Nelson DS
J Reticuloendothel Soc; 1979 Sep; 26(3):259-71. PubMed ID: 115998
[No Abstract] [Full Text] [Related]
13. Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammalian macrophage activation factor (s).
Hibbs JB; Weinberg JB; Chapman HA
Adv Exp Med Biol; 1979; 121B():433-53. PubMed ID: 232620
[No Abstract] [Full Text] [Related]
14. Polyclonal activation of murine B lymphocytes by Fc fragments. III. Characterization of the defect in the ability of the C3H/HeJ mouse to respond to Fc fragments.
Morgan EL; Weigle WO
J Immunol; 1980 Dec; 125(6):2467-72. PubMed ID: 7000901
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
Ruco LP; Meltzer MS
J Immunol; 1978 Nov; 121(5):2035-42. PubMed ID: 712076
[No Abstract] [Full Text] [Related]
16. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
Rashid G; Gittel H; Ben-Efraim S
Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of peripheral leukocyte response to endotoxin in mice.
Verghese MW; Prince M; Snyderman R
J Immunol; 1980 May; 124(5):2468-73. PubMed ID: 7365261
[No Abstract] [Full Text] [Related]
18. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages.
Nacy CA; Leonard EJ; Meltzer MS
J Immunol; 1981 Jan; 126(1):204-7. PubMed ID: 7005333
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation for tumor cytotoxicity: tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli.
Ruco LP; Meltzer MS
Cell Immunol; 1978 Nov; 41(1):35-51. PubMed ID: 363288
[No Abstract] [Full Text] [Related]
20. Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions.
Meltzer MS; Ruco LP; Boraschi D; Nacy CA
J Reticuloendothel Soc; 1979 Oct; 26(4):403-15. PubMed ID: 390144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
